These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

294 related articles for article (PubMed ID: 15122004)

  • 1. Incidence of hepatotoxicity due to antitubercular medicines and assessment of risk factors.
    Shakya R; Rao BS; Shrestha B
    Ann Pharmacother; 2004 Jun; 38(6):1074-9. PubMed ID: 15122004
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Incidence of antituberculosis-drug-induced hepatotoxicity and associated risk factors among tuberculosis patients in Dawro Zone, South Ethiopia: A cohort study.
    Wondwossen Abera ; Waqtola Cheneke ; Gemeda Abebe
    Int J Mycobacteriol; 2016 Mar; 5(1):14-20. PubMed ID: 26927985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of risk factors for antituberculosis treatment induced hepatotoxicity.
    Singla R; Sharma SK; Mohan A; Makharia G; Sreenivas V; Jha B; Kumar S; Sarda P; Singh S
    Indian J Med Res; 2010 Jul; 132():81-6. PubMed ID: 20693595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Drug-induced hepatotoxicity caused by anti-tuberculosis drugs in tuberculosis patients complicated with chronic hepatitis].
    Kaneko Y; Nagayama N; Kawabe Y; Shimada M; Suzuki J; Kunogi M; Matsui Y; Kawashima M; Suzuki J; Ariga H; Oshima N; Masuda K; Matsui H; Nagai H; Tamura A; Akagawa S; Toyoda E; Machida K; Kurashima A; Yotsumoto H
    Kekkaku; 2008 Jan; 83(1):13-9. PubMed ID: 18283910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for antituberculous chemotherapy-induced hepatotoxicity in Japanese pediatric patients.
    Ohkawa K; Hashiguchi M; Ohno K; Kiuchi C; Takahashi S; Kondo S; Echizen H; Ogata H
    Clin Pharmacol Ther; 2002 Aug; 72(2):220-6. PubMed ID: 12189369
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inactive hepatitis B surface antigen carrier state and hepatotoxicity during antituberculosis chemotherapy.
    Lee BH; Koh WJ; Choi MS; Suh GY; Chung MP; Kim H; Kwon OJ
    Chest; 2005 Apr; 127(4):1304-11. PubMed ID: 15821209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatotoxicity due to first-line anti-tuberculosis drugs: a five-year experience in a Taiwan medical centre.
    Shu CC; Lee CH; Lee MC; Wang JY; Yu CJ; Lee LN
    Int J Tuberc Lung Dis; 2013 Jul; 17(7):934-9. PubMed ID: 23743313
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Common risk factors for the development of anti tuberculosis treatment induced hepatotoxicity.
    Abbasi MA; Ahmed N; Suleman A; Zaman H; Tariq S; Anwar SA; Khan N
    J Ayub Med Coll Abbottabad; 2014; 26(3):384-8. PubMed ID: 25671954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Secular increase in the incidence rate of drug-induced hepatitis due to anti-tuberculosis chemotherapy including isoniazid and rifampicin].
    Nagayama N; Masuda K; Baba M; Tamura A; Nagai H; Akagawa S; Kawabe Y; Machida K; Kurashima A; Yotsumoto H; Mohri M
    Kekkaku; 2003 Apr; 78(4):339-46. PubMed ID: 12739393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Six-months chemotherapy (2HRZS or E/4HRE) of new cases of pulmonary tuberculosis--six year experiences on its effectiveness, toxicity, and acceptability].
    Wada M; Yoshiyama T; Ogata H; Ito K; Mizutani S; Sugita H
    Kekkaku; 1999 Apr; 74(4):353-60. PubMed ID: 10355221
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early monitoring for detection of antituberculous drug-induced hepatotoxicity.
    Lee CM; Lee SS; Lee JM; Cho HC; Kim WS; Kim HJ; Ha CY; Kim HJ; Kim TH; Jung WT; Lee OJ
    Korean J Intern Med; 2016 Jan; 31(1):65-72. PubMed ID: 26767859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety of an ofloxacin-based antitubercular regimen for the treatment of tuberculosis in patients with underlying chronic liver disease: a preliminary report.
    Saigal S; Agarwal SR; Nandeesh HP; Sarin SK
    J Gastroenterol Hepatol; 2001 Sep; 16(9):1028-32. PubMed ID: 11595068
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of acute viral hepatitis as a confounding factor in antituberculosis treatment induced hepatotoxicity.
    Sarda P; Sharma SK; Mohan A; Makharia G; Jayaswal A; Pandey RM; Singh S
    Indian J Med Res; 2009 Jan; 129(1):64-7. PubMed ID: 19287059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of risk factors on the severity of anti-tuberculosis drug-induced hepatotoxicity.
    Fernández-Villar A; Sopeña B; Fernández-Villar J; Vázquez-Gallardo R; Ulloa F; Leiro V; Mosteiro M; Piñeiro L
    Int J Tuberc Lung Dis; 2004 Dec; 8(12):1499-505. PubMed ID: 15636498
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of antitubercular drugs-induced hepatotoxicity and therapy reintroduction strategy in a TB clinic of Nepal.
    Shakya R; Rao BS; Shrestha B
    Kathmandu Univ Med J (KUMJ); 2005; 3(1):45-9. PubMed ID: 16401944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of Risk Factors for Development of Anti-Tubercular Therapy Induced Hepatotoxicity: A Prospective Study.
    Subbalaxmi MVS; Soanker R; Lakshmi AV
    Curr Drug Saf; 2020; 15(3):198-204. PubMed ID: 32589563
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antituberculosis drugs and hepatotoxicity among hospitalized patients in Jos, Nigeria.
    Isa SE; Ebonyi AO; Shehu NY; Idoko P; Anejo-Okopi JA; Simji G; Odesanya RU; Abah IO; Jimoh HO
    Int J Mycobacteriol; 2016 Mar; 5(1):21-6. PubMed ID: 26927986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors for hepatotoxicity associated with rifampin and pyrazinamide for the treatment of latent tuberculosis infection: experience from three public health tuberculosis clinics.
    Lee AM; Mennone JZ; Jones RC; Paul WS
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):995-1000. PubMed ID: 12475146
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective clinical study of isoniazid-rifampicin-pyrazinamide-induced liver injury in an area endemic for hepatitis B.
    Hwang SJ; Wu JC; Lee CN; Yen FS; Lu CL; Lin TP; Lee SD
    J Gastroenterol Hepatol; 1997 Jan; 12(1):87-91. PubMed ID: 9076631
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Isoniazid hepatotoxicity associated with treatment of latent tuberculosis infection: a 7-year evaluation from a public health tuberculosis clinic.
    Fountain FF; Tolley E; Chrisman CR; Self TH
    Chest; 2005 Jul; 128(1):116-23. PubMed ID: 16002924
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.